Letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.
作者信息
Önder Arif Hakan
机构信息
Antalya Training and Research Hospital, Antalya, Türkiye.
出版信息
ESMO Open. 2025 May;10(5):105066. doi: 10.1016/j.esmoop.2025.105066. Epub 2025 Apr 30.
Abstract
摘要
相似文献
1
Letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.信件回复：管腔样亚型在激素受体阳性乳腺癌中的预后及预测价值：DATA试验分析
ESMO Open. 2025 May;10(5):105066. doi: 10.1016/j.esmoop.2025.105066. Epub 2025 Apr 30.
2
Response to letter re: The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.对关于“激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析”的信件的回复
ESMO Open. 2025 May;10(5):105068. doi: 10.1016/j.esmoop.2025.105068. Epub 2025 Apr 16.
3
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析
ESMO Open. 2025 Feb;10(2):104154. doi: 10.1016/j.esmoop.2025.104154. Epub 2025 Feb 7.
4
Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.孕激素受体亚型在雌激素受体阳性、HER-2 阴性乳腺癌患者中的预后价值。
Oncologist. 2019 Feb;24(2):165-171. doi: 10.1634/theoncologist.2018-0176. Epub 2018 Aug 31.
5
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.来曲唑联合或不联合拉帕替尼治疗激素受体阳性转移性乳腺癌的内在亚型的预后价值。
JAMA Oncol. 2016 Oct 1;2(10):1287-1294. doi: 10.1001/jamaoncol.2016.0922.
6
Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.依维莫司联合依西美坦治疗激素受体阳性晚期乳腺癌：BOLERO-2 研究的 PAM50 内在亚型分析。
Oncologist. 2019 Jul;24(7):893-900. doi: 10.1634/theoncologist.2018-0407. Epub 2019 Jan 24.
7
Letter re: A critical appraisal of the DATA trial analysis on the prognostic and predictive value of the luminal-like subtype.关于《 luminal样亚型的预后和预测价值的DATA试验分析的批判性评价》的信件
ESMO Open. 2025 May;10(5):105067. doi: 10.1016/j.esmoop.2025.105067. Epub 2025 Apr 15.
8
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5.激素受体阳性早期乳腺癌绝经前女性分子亚型的预测价值：来自 ABCSG 试验 5 的结果。
Clin Cancer Res. 2020 Nov 1;26(21):5682-5688. doi: 10.1158/1078-0432.CCR-20-0673. Epub 2020 Jun 16.
9
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.乳腺癌中激素受体状态和肿瘤亚型对年轻 BRCA 携带者的影响。
Ann Oncol. 2024 Sep;35(9):792-804. doi: 10.1016/j.annonc.2024.06.009. Epub 2024 Jun 20.
10
Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.激素受体阳性/人表皮生长因子受体 2 阴性早期乳腺癌中基因组或中央分级及免疫组织化学亚型或 IHC4 对预后和预测影响的比较：WSG-AGO EC-Doc 试验。
Ann Oncol. 2016 Jun;27(6):1035-1040. doi: 10.1093/annonc/mdw070. Epub 2016 Feb 18.
本文引用的文献
1
The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial.激素受体阳性乳腺癌中腔面样亚型的预后和预测价值：DATA试验分析
ESMO Open. 2025 Feb;10(2):104154. doi: 10.1016/j.esmoop.2025.104154. Epub 2025 Feb 7.
2
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.内分泌治疗5年后停药的乳腺癌20年复发风险
N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.
3
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers.乳腺癌患者内分泌治疗反应的准确预测：当前及未来的生物标志物
Breast Cancer Res. 2016 Dec 1;18(1):118. doi: 10.1186/s13058-016-0779-0.
4
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.激素受体阳性乳腺癌女性的辅助内分泌治疗：美国临床肿瘤学会临床实践指南重点更新
J Clin Oncol. 2014 Jul 20;32(21):2255-69. doi: 10.1200/JCO.2013.54.2258. Epub 2014 May 27.
5
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.免疫组化定义的 luminal A 型乳腺癌中孕激素受体阳性肿瘤细胞的预后意义。
J Clin Oncol. 2013 Jan 10;31(2):203-9. doi: 10.1200/JCO.2012.43.4134. Epub 2012 Dec 10.
Zotero 插件